Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series : World's leading Event Organizer

Back


Cohen Ilana

Immunity Pharma Ltd., Israel

Biography

Ilana Cohen earned her Ph.D. in neurobiology at the Weizmann Institute of Science, Israel.  She has more than 20 years of experience in scientific management of drug development, leading multidisciplinary projects from initial drug discovery stages to clinical trials. As part of Immunity Pharma (IPL) management her main goal is helping people living with neurodegenerating disorders by developing innovative therapies.  She leads the development of Immunity Pharma’s novel technology platform that focuses on receptor-independent activation of the pro-survival Akt pathway, a key pathway in preventing neurodegeneration. IPL's first drug candidate targets Amyotrophic Lateral sclerosis (ALS) is currently evaluated in exploratory open label Phase 2a clinical trial with ALS patients.

Abstract

Abstract : Peptide IPL344, an AKT activator, treats SOD1 ALS model mice to improve neuro-muscular function